Navigation Links
PKG in the On Position Results in Chronic Pain

Richard Ambron from Columbia University in New York City has discovered that chronic pain occurs as a result of hyper-excitable neurons. //

He and his colleagues were studying chronic pain at the molecular and cellular level. Normally at the molecular level a pain stimulus occurs and the neurons becomes excited and begin to send signals to the brain and the individual sense pain but when the stimulus is removed the nerves become dormant and there is no sense of pain. In case of patients suffering from chronic pain the nerves remain the hyper- excitable stage and remains so even if there is a very mild stimulus.

This is because of the enzyme called protein kinase G or PKG. if it is in the on position then the nerves keep sending signals long after the injury that originally caused the pain has healed. Hence drugs should be developed to target this enzyme and shut down the enzyme. It is a new approach to pain relief for the millions suffering from chronic pain. Statistics show that about 48 million Americans suffer from long-lasting pain. Current pain drugs have side effects such as drowsiness and sometimes do not work with certain individuals. The study is done in mice and will be published in the journal Neuroscience.


'"/>




Page: 1

Related medicine news :

1. Sleeping Position Speaks A Lot About The Couples Relationship
2. Vitamin D In Pole Position At Clinical Endocrinologists Meet
3. Two New Anesthesia Positions Promise to Ease Surgery Queue
4. Hormone Deficiency Results In Miscarriage
5. Breast Implants May Interfere With The Interpretation Of Mammogram Results
6. DNA Testing For More Accurate Results
7. Operating on a Beating Heart Yields Better Results For Blocked Heart Arteries
8. Intense Fight Against Polio In India Gets Results
9. Deadly Diarrhoea Vaccine – Trail Results Promising
10. Novartis MS Drug Shows Promising Results
11. Results Of Human Trials Of Hungarian Bird-Flu Vaccine Expected Today
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)... ... ... TherapySites, the leading website and online marketing ... Association. This new relationship allows TherapySites to continue to extend their online ... and promotional offers. , "TCA is extremely excited about this new partnership, as ...
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer care, and ... in the eye of the beholder, according to experts who offered insights and commentary ... of Managed Care. For the full issue, click here . , For the ...
(Date:6/26/2016)... ... June 26, 2016 , ... Brent Kasmer, a legally blind and certified personal trainer is helping ... fitness app. The fitness app plans to fix the two major problems leading the fitness ... size fits all type program , They don’t eliminate all the reasons people ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library ... City Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ... for fumigation is not a common occurrence, but a necessary one in the event that ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016  Global Blood Therapeutics, Inc. (GBT) ... developing novel therapeutics for the treatment of grievous ... the closing of its previously announced underwritten public ... the public offering price of $18.75 per share. ... offered by GBT. GBT estimates net proceeds from ...
(Date:6/24/2016)... 24, 2016 ... the addition of the " Global Markets for ... This report focuses on ... updated review, including its applications in various applications. The ... which includes three main industries: pharmaceutical and biotechnology, food ...
(Date:6/24/2016)... -- The Academy of Managed Care Pharmacy (AMCP) today ... allow biopharmaceutical companies to more easily share health care ... coverage decisions, a move that addresses the growing need ... The recommendations address restrictions in the sharing of product ... a prohibition that hinders decision makers from accessing HCEI ...
Breaking Medicine Technology: